Description
Celdaz 200mg Injection: A Comprehensive Overview
Celdaz 200mg Injection contains Doxorubicin, a powerful anthracycline chemotherapy drug. Doctors use it to treat a wide range of cancers, including breast cancer, leukemia, non-Hodgkin’s lymphoma, and sarcomas. As an anthracycline, Doxorubicin’s primary mechanism of action involves a dual attack on cancer cell DNA. Firstly, it works by intercalating into DNA, which means it wedges itself between the base pairs of the genetic material, disrupting its structure. Secondly, it also inhibits the enzyme topoisomerase II, a protein crucial for DNA replication. This inhibition prevents the DNA strands from unwinding and re-sealing, leading to irreversible DNA damage. Consequently, these combined actions lead to rapid cancer cell death, making Doxorubicin one of the most widely used and effective agents in oncology.
Usage, Administration, and Therapeutic Protocols
A healthcare professional typically administers this injection intravenously in a hospital or clinical setting. Due to its potency and the risk of extravasation (the drug leaking from the vein and damaging surrounding tissue), a medical professional must carefully supervise the infusion. Furthermore, doctors usually use Doxorubicin as part of combination chemotherapy regimens to enhance its overall efficacy. For instance, in breast cancer, it is a key component of the AC regimen (Adriamycin and Cyclophosphamide). The dosage and administration schedule depend on the type of cancer, the patient’s body surface area, and their response to therapy. Due to the risk of cumulative toxicity, there is a lifetime dose limit for the drug.
Manufacturing, Safety, and Monitoring
Celon Labs manufactures Celdaz 200mg Injection. While it offers a significant therapeutic benefit, it also comes with notable side effects that require careful management. A major concern is cardiotoxicity, which can lead to damage to the heart muscle and, in some cases, congestive heart failure. Therefore, doctors must regularly monitor a patient’s heart function, often using echocardiograms, both before and during therapy, especially with long-term use. Other common side effects include nausea, vomiting, and hair loss. Moreover, like many chemotherapy drugs, Doxorubicin causes bone marrow suppression, so doctors must consistently monitor a patient’s blood counts to manage risks of infection and anemia.
Availability & Purchase Information
Genetec Lifesciences makes Celdaz 200mg Injection available. To place an order or request a quote, please contact us directly. We ensure that we source all products from verified and authorized vendors.
Disclaimer
This site provides product information for informative purposes only. The product image belongs to its respective company. Genetec Lifesciences acts as a wholesaler and distributor, not a manufacturer. We source our medicines directly from the company or its authorized vendors.